Jefferies Maintains a Buy on Inspire Medical Systems (INSP) With a $160 PT

Inspire Medical Systems, Inc. (NYSE:INSP) is one of the best medical device stocks to buy according to analystsJefferies analyst Michael Sarcone maintained a Buy rating on Inspire Medical Systems, Inc. (NYSE:INSP) on August 5, setting a price target of $160.00.

A medical professional performing a minimally invasive procedure while using the company’s technology.

The rating update followed Inspire Medical Systems, Inc.’s (NYSE:INSP) release of fiscal Q2 2025 results on August 4. The company generated $217.1 million in revenue in fiscal Q2 2025, reflecting an 11% growth over the same quarter in 2024.

It achieved a gross margin of 84.0%, while net loss for the quarter was $3.6 million. Inspire Medical Systems, Inc. (NYSE:INSP) also reported adjusted diluted earnings per share of $0.45.

Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company that develops and commercializes innovative, minimally invasive solutions for obstructive sleep apnea.

The company offers Inspire therapy, which includes implantable components with a pressure-sensing lead, a stimulation lead, and a neurostimulator, operable through a remote control.

While we acknowledge the potential of INSP to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than INSP and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.